2Dawson DL, Cutler KS, Hiatt WR, et al.. A comparison of cilostazol and pentoxifynine for treating intermittent claudication[J]. Am J Med, 2000, 109: 523 - 530. 被引量：1
3ATS statement: guidelines for the six-minute walk test. ATS Committee on proficiency standards for clinical pulmonary function laboratories[J], Am J Respir Crit Care Med, 2002,166( 1 ) : 111 - 117. 被引量：1
8De Franciscis S, Gallelli L, Battaglia L, et al. Cilostazol prevents foot ul- cers in diabetic patients with peripheral vascular disease[J]. Int Wound J, 2013,3:15. 被引量：1
9Souza junior SS, Moreira Neto AA, Lemos JB, et al. Biochemical study if the effects if cilostazal in rats subjected to acute ischemia and ischemia and reperfusion if hind limbs[J]. Acta Cir Bras,2013,28(5) :361 - 366. 被引量：1
6Regensteiner J, Ware J J, McCarthy W, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials [J]. J Am Geriatr Soc, 2002, 50:1939- 1946. 被引量：1
7Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication[J]. AmJ Med,2000, 109:523-530. 被引量：1
9ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Meal,2002,166 (1): 111-117. 被引量：1
10Kohda N, Tani T, Nakayama S, et al. Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. Thromb Res, 1999,96(4) :261-268. 被引量：1
